Valganciclovir
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Vanderbilt University Medical Center
Overview
Valganciclovir is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Valganciclovir clinical trials
Explore related
Medical disclaimer. This page summarizes research about Valganciclovir for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.